BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6440214)

  • 1. Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase.
    Maclouf J; Levy-Toledano S; Savariau E; Hardisty R; Caen JP
    Prostaglandins; 1984 Sep; 28(3):383-98. PubMed ID: 6440214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes.
    Smith JB; Dangelmaier C; Mauco G
    Biochim Biophys Acta; 1985 Jul; 835(2):344-51. PubMed ID: 3924113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of ADP-induced Ca2+-signal and platelet aggregation by lipoxygenase inhibitors.
    Borin ML; Pinelis VG; Ivanova MA; Kudinov YuV ; Azizova OA; Markov CM; Khodorov BI
    FEBS Lett; 1989 Nov; 257(2):345-7. PubMed ID: 2511040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of arachidonic acid metabolism on intravascular platelet aggregation in rats.
    Mallarkey G; Smith GM
    Thromb Res; 1984 Oct; 36(2):91-102. PubMed ID: 6438829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: comparison with indomethacin and ETYA.
    Van Wauwe J; Goossens J
    Prostaglandins; 1983 Nov; 26(5):725-30. PubMed ID: 6422509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Ca2+ mobilizing action of arachidonic acid in human platelets.
    Tohmatsu T; Nakashima S; Nozawa Y
    Biochim Biophys Acta; 1989 Jun; 1012(1):97-102. PubMed ID: 2499358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tert-butyl hydroperoxide on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in rabbit platelets.
    Fujimoto Y; Takai S; Matsuno K; Sumiya T; Nishida H; Sakuma S; Fujita T
    Prostaglandins Leukot Essent Fatty Acids; 1992 Dec; 47(4):259-64. PubMed ID: 1492102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some properties of mouse platelets.
    Rosenblum WI; Nelson GH; Cockrell CS; Ellis EF
    Thromb Res; 1983 May; 30(4):347-55. PubMed ID: 6412387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible platelet aggregation does not depend on lipoxygenase metabolites.
    Rao GH; Radha E; White JG
    Biochem Biophys Res Commun; 1985 Aug; 131(1):50-7. PubMed ID: 3929780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the two pathways for arachidonate oxygenation in blood platelets.
    Dutilh CE; Haddeman E; Jouvenaz GH; Ten Hoor F; Nugteren DH
    Lipids; 1979 Feb; 14(2):241-6. PubMed ID: 34075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
    Boukili MA; Bureau M; Lagente V; Lefort J; Lellouch-Tubiana A; Malanchère E; Vargaftig BB
    Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets.
    Schafer AI; Turner NA; Handin RI
    Biochim Biophys Acta; 1982 Sep; 712(3):535-41. PubMed ID: 6812645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of AA-861, a 5-lipoxygenase inhibitor, on leukotriene synthesis in human polymorphonuclear leukocytes and on cyclooxygenase and 12-lipoxygenase activities in human platelets.
    Mita H; Yui Y; Shida T
    Allergy; 1986 Sep; 41(7):493-8. PubMed ID: 3024521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of aspirin and non steroidal anti-inflammatory drugs on the formation of 12-hydroxyeicosatetraenoic acid by platelets.
    Tremoli E; Maderna P; Eynard A; Gregori M; Galli G
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):117-22. PubMed ID: 3094026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.